GlassScriptPhysician profile
Haina Patel
NPI 1851813448
$1,261.09
in general payments reported to CMS, 2019-2025
19 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.29 · 2021: $209 · 2022: $281 · 2023: $114 · 2024: $251 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $201.97 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $200.13 | 2023-2025 | Rocklatan, Tryptyr, Clareon |
| Johnson & Johnson Vision Care, INC. | $119.41 | 2022 | |
| Abbvie INC. | $97.37 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $84.22 | 2023-2025 | Xiidra, Miebo |
| Kala Pharmaceuticals, INC. | $76.64 | 2021-2022 | |
| Oyster Point Pharma, INC. | $60.23 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Rxsight INC | $55.89 | 2024-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Coopervision INC. | $51.72 | 2022-2023 | Biofinity Contact Lens, Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $50.56 | 2021-2025 | |
| Allergan, INC. | $47.00 | 2021 | |
| Aerie Pharmaceuticals, INC. | $45.74 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $43.40 | 2021-2022 | |
| Horizon Therapeutics Plc | $32.09 | 2022 | |
| Harrow Eye, LLC | $29.49 | 2025 | Vevye |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synergeyes, INC. | $19.69 | 2021 | |
| Thea Pharma INC. | $18.96 | 2024 | Iyuzeh |
| Dompe US, INC. | $15.82 | 2022 | |
| Tearlab Corp | $10.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haina Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.